ERLOCIP ERLOTINIB TABLETS IP

Get a Price/Quote

ERLOCIP ERLOTINIB TABLETS IP Specification

Indication
Non-Small Cell Lung Cancer, Pancreatic Cancer

Dosage Form
Film-coated Tablet

Salt Composition
Erlotinib Hydrochloride (equivalent to Erlotinib) 150 mg

Feature
Oral Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor

Ingredients
Erlotinib Hydrochloride, Excipients

Application
Anticancer Therapy

Physical Color/Texture
White to off-white, round, film-coated tablets

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from light and moisture

Shelf Life
24 months

ERLOCIP ERLOTINIB TABLETS IP Trade Information

Packaging Details
Pack of 30 tablets - Erlocip

Main Domestic Market
All India

Certifications
Composition:Erlotinib hydrochloride Manufactured By:Cipla Usage:Hospital No of tablets:30 Brand:Erlocip Form of Medicine:Tablets Dose:150mg Dose/Strength:100mg/ 150mg

About ERLOCIP ERLOTINIB TABLETS IP

Erlocip 150Mg Erlotinib

ERLOCIP 150 MG TABLETS - ERLOTINIB HYDROCHLORIDE

Erlocip Tablets Contains Erlotinib And Its Available As : 100 Mg & 150 Mg Tablets.

Specification :-

Composition:Erlotinib hydrochloride
Manufactured By:Cipla
Usage:Hospital
No of tablets:30
Brand:Erlocip
Form of Medicine:Tablets
Dose:150mg
Dose/Strength:100mg/ 150mg

Note: Erlocip Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug...............

Targeted Anticancer Solution

ERLOCIP Erlotinib Tablets deliver targeted therapy for patients with non-small cell lung cancer and pancreatic cancer. By inhibiting the EGFR tyrosine kinase, these tablets help slow or stop the proliferation of cancer cells. Their oral administration makes them convenient for long-term cancer management under an oncologists guidance.

Simple Oral Administration

Designed for ease of use, ERLOCIP tablets are taken orally as prescribed by a healthcare specialist. Their film-coated formulation ensures smooth ingestion and precise dosing. Always follow your oncologists instructions regarding timing and dosage for optimal therapeutic effects and safety.

Safe Storage and Handling

ERLOCIP should always be kept in its original bottle, tightly closed, away from light and moisture, and stored below 30C. Proper storage protects the medications integrity during its 24-month shelf life. For any unused or expired medicine, follow your pharmacists or oncologists directions for safe disposal.

FAQs of ERLOCIP ERLOTINIB TABLETS IP:

Q: How should ERLOCIP Erlotinib 150 mg tablets be taken?

A: ERLOCIP should be taken orally exactly as prescribed by your oncologist, usually once daily, with or without food. Do not adjust your dosage without professional guidance.

Q: What is ERLOCIP 150 mg used for?

A: This medication is indicated for the treatment of non-small cell lung cancer and pancreatic cancer, specifically in patients whose cancer involves the epidermal growth factor receptor (EGFR) pathway.

Q: When should I take ERLOCIP tablets?

A: Its recommended to take ERLOCIP at the same time every day for best results. Always adhere to the schedule provided by your healthcare professional.

Q: Where should ERLOCIP be stored?

A: Store ERLOCIP tablets in their original packaging at temperatures below 30C, protected from light and moisture. Avoid removing the tablets from the bottle until ready to use each dose.

Q: What benefits does ERLOCIP offer in cancer therapy?

A: ERLOCIP targets the EGFR tyrosine kinase, potentially slowing cancer cell growth and improving outcomes for eligible patients with non-small cell lung or pancreatic cancer.

Q: What should I do if I miss a dose of ERLOCIP?

A: If you miss a dose, take it as soon as you remember unless its almost time for your next dose. Never take two doses at once, and consult your doctor for further instructions.

Tell us about your requirement